HomeDVYSF • OTCMKTS
add
Devyser Diagnostics AB
Market news
Simply Wall St
33 minutes ago
Vertex Insider Sales Contrast With Analyst Targets And Valuation Signals
3.48%
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 72.00M | 12.15% |
Operating expense | 39.10M | -32.59% |
Net income | 13.60M | 525.00% |
Net profit margin | 18.89 | 479.32% |
Earnings per share | — | — |
EBITDA | 23.50M | 921.74% |
Effective tax rate | 15.00% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 77.50M | -46.37% |
Total assets | 469.70M | -0.87% |
Total liabilities | 115.40M | -7.53% |
Total equity | 354.30M | — |
Shares outstanding | 16.65M | — |
Price to book | — | — |
Return on assets | 9.74% | — |
Return on capital | 11.33% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 13.60M | 525.00% |
Cash from operations | 11.70M | 935.71% |
Cash from investing | -15.60M | 28.11% |
Cash from financing | -3.10M | — |
Net change in cash | -7.40M | 72.49% |
Free cash flow | -9.00M | 66.28% |
About
Founded
2004
Website
Employees
116
